Paydirt
DR
Insider

David Malcom Rodman

Chief Medical Officer

David Malcom Rodman (Chief Medical Officer) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Mineralys Therapeutics, Inc. (MLYS). The largest single filing was $9.3M of MLYS (262,752 sh across 3 lots, as filed), executed Jan 2.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
11
0 buys · 11 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$13.6M
shares × price, as filed
Last traded
Jul 15
Filed Jul 15

Median ADV $38.0M across their filed names

Open performance
Volume by month
$10.1M$5.0M$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2024 · sells $383KApr 2025 · sells $959KMay 2025 · sells $174KJun 2025 · sells $166KJul 2025 · sells $166KAug 2025 · sells $147KSep 2025 · sells $334KOct 2025 · sells $446KJan 2026 · sells $10.1MFeb 2026 · sells $458KMar 2026 · sells $452KApr 2026 · sells $549KMay 2026 · sells $588KJun 2026 · sells $502KJul 2026 · sells $557K
Buys $0 Sells $16.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 11 filings

Sector per market data · by filing · past 12 months

Most traded names
MLYS Mineralys Therapeutics, Inc. MLYS · 0 buys · 19 sells 19 filings
Recent filings
MLYSSALE Mineralys Therapeutics, Inc. View filing → $205K
6,348 sh × $32.32
Exec Jan 12
Filed Jan 13 · 5:30 PM ET
MLYSSALE Mineralys Therapeutics, Inc. View filing → $9.3M
262,752 sh across 3 lots
Exec Jan 2
Filed Jan 6 · 5:30 PM ET
MLYSSALE Mineralys Therapeutics, Inc. View filing → $446K
10,369 sh × $43.01
Exec Oct 15 2025
Filed Oct 15 2025 · 5:30 PM ET
MLYSSALE Mineralys Therapeutics, Inc. View filing → $334K
9,302 sh × $35.90
Exec Sep 15 2025
Filed Sep 16 2025 · 5:30 PM ET
MLYSSALE Mineralys Therapeutics, Inc. View filing → $147K
11,365 sh × $12.93
Exec Aug 13 2025
Filed Aug 14 2025 · 5:30 PM ET
MLYSSALE Mineralys Therapeutics, Inc. View filing → $166K
11,366 sh × $14.59
Exec Jul 14 2025
Filed Jul 15 2025 · 5:30 PM ET
MLYSSALE Mineralys Therapeutics, Inc. View filing → $166K
11,366 sh × $14.60
Exec Jun 13 2025
Filed Jun 16 2025 · 5:30 PM ET
MLYSSALE Mineralys Therapeutics, Inc. View filing → $174K
11,366 sh × $15.29
Exec May 14 2025
Filed May 15 2025 · 5:30 PM ET
More filings →